Search

Your search keyword '"Di Fusco, Stefania Angela"' showing total 320 results
Start Over Author "Di Fusco, Stefania Angela"
320 results on '"Di Fusco, Stefania Angela"'

2. Correction: Acute pulmonary embolism and cancer: findings from the COPE study

Author

Becattini, Cecilia, Cimini, Ludovica Anna, Bassanelli, Giorgio, Maggioni, Aldo P., Pomero, Fulvio, Lobascio, Ilaria, Enea, Iolanda, Pomata, Daniela P., Ruggieri, Maria Pia, Zalunardo, Beniamino, Novelli, Anna, Di Fusco, Stefania Angela, Triggiani, Marco, Marzolo, Marco, Fioravanti, Chiara, Agnelli, Giancarlo, Gonzini, Lucio, and Gulizia, Michele M.

Published
2024
Full Text
View/download PDF

4. Acute pulmonary embolism and cancer: findings from the COPE study

Author

Becattini, Cecilia, Cimini, Ludovica Anna, Bassanelli, Giorgio, Maggioni, Aldo P., Pomero, Fulvio, Lobascio, Ilaria, Enea, Iolanda, Pomata, Daniela P., Ruggieri, Maria Pia, Zalunardo, Beniamino, Novelli, Anna, Di Fusco, Stefania Angela, Triggiani, Marco, Marzolo, Marco, Fioravanti, Chiara, Agnelli, Giancarlo, Gonzini, Lucio, and Gulizia, Michele M.

Published
2024
Full Text
View/download PDF

11. Antibiotic Prophylaxis and Treatment for Cardiac Device Infections.

Author

Pandozi, Claudio, Matteucci, Andrea, Pignalberi, Carlo, Sgarra, Luca, Bonanni, Michela, Mariani, Marco Valerio, La Fazia, Vincenzo Mirco, Nesti, Lorenzo, Di Fusco, Stefania Angela, Nardi, Federico, and Colivicchi, Furio

Subjects
INFECTION prevention, ARTIFICIAL implants, ELECTRONIC equipment, MEDICAL care costs, EARLY diagnosis, ANTIBIOTIC prophylaxis
Abstract

Cardiac device infections (CDIs) are a serious complication in patients with implanted devices, resulting in increased morbidity, prolonged hospital stay, and increased healthcare costs. The effective management of these infections involves a combination of appropriate antibiotic therapy and preventive strategies aimed at reducing the risk of infection. The role of antibiotic prophylaxis in infection prevention is crucial, including the emerging use of antibiotic-supported tools and other local antibiotic delivery systems, which may reduce the risk of infection at the device implant site. In this contemporary review, we provide an overview of the prophylactic treatment and different antibiotic regimens for the treatment of CDIs, emphasizing early diagnosis, appropriate choice of antibiotics, and individualized treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Exploring the Perioperative Use of DOACs, off the Beaten Track

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Giubilato, Simona, additional, Abrignani, Maurizio Giuseppe, additional, Rao, Carmelo Massimiliano, additional, Cornara, Stefano, additional, Caretta, Giorgio, additional, Di Fusco, Stefania Angela, additional, Ceravolo, Roberto, additional, Parrini, Iris, additional, Murrone, Adriano, additional, Geraci, Giovanna, additional, Riccio, Carmine, additional, Gelsomino, Sandro, additional, Colivicchi, Furio, additional, Grimaldi, Massimo, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

13. Coagulation Tests and Reversal Agents in Patients Treated with Oral Anticoagulants: The Challenging Scenarios of Life-Threatening Bleeding and Unplanned Invasive Procedures

Author

Pozzi, Andrea, primary, Lucà, Fabiana, additional, Gelsomino, Sandro, additional, Abrignani, Maurizio Giuseppe, additional, Giubilato, Simona, additional, Di Fusco, Stefania Angela, additional, Rao, Carmelo Massimiliano, additional, Cornara, Stefano, additional, Caretta, Giorgio, additional, Ceravolo, Roberto, additional, Parrini, Iris, additional, Geraci, Giovanna, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, Oliva, Fabrizio, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

14. Remote monitoring: Doomed to let down or an attractive promise?

Author

Lucà, Fabiana, Cipolletta, Laura, Di Fusco, Stefania Angela, Iorio, Annamaria, Pozzi, Andrea, Rao, Carmelo Massimiliano, Ingianni, Nadia, Benvenuto, Manuela, Madeo, Andrea, Fiscella, Damiana, Benedetto, Daniela, Francese, Giuseppina Maura, Gelsomino, Sandro, Zecchin, Massimo, Gabrielli, Domenico, and Gulizia, Michele Massimo

Published
2019
Full Text
View/download PDF

15. Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Abrignani, Maurizio Giuseppe, additional, Di Fusco, Stefania Angela, additional, Gori, Mauro, additional, Giubilato, Simona, additional, Ceravolo, Roberto, additional, Temporelli, Pier Luigi, additional, Cornara, Stefano, additional, Rao, Carmelo Massimiliano, additional, Caretta, Giorgio, additional, Pozzi, Andrea, additional, Binaghi, Giulio, additional, Maloberti, Alessandro, additional, Di Nora, Concetta, additional, Di Matteo, Irene, additional, Pilleri, Anna, additional, Gelsomino, Sandro, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2024
Full Text
View/download PDF

16. Aspirin in Primary Prevention: Looking for Those Who Enjoy It.

Author

Della Bona, Roberta, Giubilato, Simona, Palmieri, Marco, Benenati, Stefano, Rossini, Roberta, Di Fusco, Stefania Angela, Novarese, Filippo, Mascia, Giuseppe, Gasparetto, Nicola, Di Monaco, Antonio, Gatto, Laura, Zilio, Filippo, Sorini Dini, Carlotta, Borrello, Francesco, Geraci, Giovanna, Riccio, Carmine, De Luca, Leonardo, Colivicchi, Furio, Grimaldi, Massimo, and Giulizia, Michele Massimo

Subjects
ANTILIPEMIC agents, ASPIRIN, CANCER prevention, CARDIOVASCULAR diseases risk factors, DISEASE risk factors
Abstract

Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of cardiovascular disease. However, despite several studies showing efficacy also in primary prevention, an unopposed excess risk of bleeding leading to a very thin safety margin is evident in subjects without a clear acute cardiovascular event. Overall, the variability in recommendations from different scientific societies for aspirin use in primary prevention is a classic example of failure of simple risk stratification models based on competing risks (atherothrombosis vs. bleeding), perceived to be opposed but intertwined at the pathophysiological level. Notably, cardiovascular risk is dynamic in nature and cannot be accurately captured by scores, which do not always consider risk enhancers. Furthermore, the widespread use of other potent medications in primary prevention, such as lipid-lowering and anti-hypertensive drugs, might be reducing the benefit of aspirin in recent trials. Some authors, drawing from specific pathophysiological data, have suggested that specific subgroups might benefit more from aspirin. This includes patients with diabetes and those with obesity; sex-based differences are considered as well. Moreover, molecular analysis of platelet reactivity has been proposed. A beneficial effect of aspirin has also been demonstrated for the prevention of cancer, especially colorectal. This review explores evidence and controversies concerning the use of aspirin in primary prevention, considering new perspectives in order to provide a comprehensive individualized approach. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals

Author

Bisceglia, Irma, primary, Canale, Maria Laura, additional, Silvestris, Nicola, additional, Gallucci, Giuseppina, additional, Camerini, Andrea, additional, Inno, Alessandro, additional, Camilli, Massimiliano, additional, Turazza, Fabio Maria, additional, Russo, Giulia, additional, Paccone, Andrea, additional, Mistrulli, Raffaella, additional, De Luca, Leonardo, additional, Di Fusco, Stefania Angela, additional, Tarantini, Luigi, additional, Lucà, Fabiana, additional, Oliva, Stefano, additional, Moreo, Antonella, additional, Maurea, Nicola, additional, Quagliariello, Vincenzo, additional, Ricciardi, Giuseppina Rosaria, additional, Lestuzzi, Chiara, additional, Fiscella, Damiana, additional, Parrini, Iris, additional, Racanelli, Vito, additional, Russo, Antonio, additional, Incorvaia, Lorena, additional, Calabrò, Fabio, additional, Curigliano, Giuseppe, additional, Cinieri, Saverio, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

22. The Challenge of Managing Atrial Fibrillation during Pregnancy

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, primary, Abrignani, Maurizio Giuseppe, primary, Russo, Maria Giovanna, primary, Parrini, Iris, primary, Cornara, Stefano, primary, Ceravolo, Roberto, primary, Rao, Carmelo Massimiliano, primary, Favilli, Silvia, primary, Pozzi, Andrea, primary, Giubilato, Simona, primary, Di Fusco, Stefania Angela, primary, Sarubbi, Berardo, primary, Calvanese, Raimondo, primary, Chieffo, Alaide, primary, Gelsomino, Sandro, primary, Riccio, Carmine, primary, Grimaldi, Massimo, primary, Colivicchi, Furio, primary, and Gulizia, Michele Massimo, primary

Published
2023
Full Text
View/download PDF

23. Updated clinical evidence and place in therapy of bempedoic acid for hypercholesterolemia: ANMCO position paper

Author

Colivicchi, Furio, Di Fusco, Stefania Angela, Scicchitano, Pietro, Caldarola, Pasquale, Murrone, Adriano, Valente, Serafina, Urbinati, Stefano, Roncon, Loris, Amodeo, Vincenzo, Aspromonte, Nadia, Cipriani, Manlio, Domenicucci, Stefano, Francese, Giuseppina Maura, Imazio, Massimo, Scotto di Uccio, Fortunato, Di Lenarda, Andrea, Gulizia, Michele Massimo, and Gabrielli, Domenico

Published
2021
Full Text
View/download PDF

25. Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice.

Author

Matteucci, Andrea, Pignalberi, Carlo, Pandozi, Claudio, Magris, Barbara, Meo, Antonella, Russo, Maurizio, Galeazzi, Marco, Schiaffini, Giammarco, Aquilani, Stefano, Di Fusco, Stefania Angela, and Colivicchi, Furio

Subjects
CARDIAC pacemakers, RISK assessment, ARTIFICIAL implants, ELECTRONIC equipment, MEDICAL care costs
Abstract

The implantation of cardiac electronic devices (CIEDs), including pacemakers and defibrillators, has become increasingly prevalent in recent years and has been accompanied by a significant rise in cardiac device infections (CDIs), which pose a substantial clinical and economic burden. CDIs are associated with hospitalizations and prolonged antibiotic therapy and often necessitate device removal, leading to increased morbidity, mortality, and healthcare costs worldwide. Approximately 1–2% of CIED implants are associated with infections, making this a critical issue to address. In this contemporary review, we discuss the burden of CDIs with their risk factors, healthcare costs, prevention strategies, and clinical management. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

28. The role of the pregnancy heart team in clinical practice

Author

Lucà, Fabiana, Colivicchi, Furio, Parrini, Iris, Russo, Maria Giovanna, Di Fusco, Stefania Angela, Ceravolo, Roberto, Riccio, Carmine, Favilli, Silvia, Rossini, Roberta, Gelsomino, Sandro, Oliva, Fabrizio, Gulizia, Michele Massimo, Lucà, Fabiana, Colivicchi, Furio, Parrini, Iri, Russo, Maria Giovanna, Di Fusco, Stefania Angela, Ceravolo, Roberto, Riccio, Carmine, Favilli, Silvia, Rossini, Roberta, Gelsomino, Sandro, Oliva, Fabrizio, and Gulizia, Michele Massimo

Subjects
postpartum followup, pre-conception counseling, corrected congenital heart disease, acquired heart disease, cardio obstetric team, pregnancy heart team, Cardiology and Cardiovascular Medicine, multidisciplinary team-Based approach
Abstract

Significant maternal and fetal morbidity and mortality risk has been shown to be associated with cardiovascular disease in pregnancy. Several determinants, such as the increasing number of females with corrected congenital heart disease in reproductive age, a more advanced maternal age associated with cardiovascular risk factors, and a greater prevalence of preexisting comorbidities related to cardiac disorders such as cancer and COVID-19), lead to a higher incidence of cardiac complications in pregnancy in the last few decades. However, adopting a multidisciplinary strategy may influence maternal and neonatal outcomes. This review aims at assessing the role of the Pregnancy Heart Team, which should ensure careful pre-pregnancy counseling, pregnancy monitoring, and delivery planning for both congenital and other cardiac or metabolic disorders, addressing several emerging aspects in the multidisciplinary team-based approach.

Published
2023
Full Text
View/download PDF

30. Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals

Author

Bisceglia, Irma, primary, Canale, Maria Laura, additional, Silvestris, Nicola, additional, Gallucci, Giuseppina, additional, Camerini, Andrea, additional, Inno, Alessandro, additional, Camilli, Massimiliano, additional, Turazza, Fabio Maria, additional, Russo, Giulia, additional, Paccone, Andrea, additional, Mistrulli, Raffaella, additional, De Luca, Leonardo, additional, Di Fusco, Stefania Angela, additional, Tarantini, Luigi, additional, Lucà, Fabiana, additional, Oliva, Stefano, additional, Moreo, Antonella, additional, Maurea, Nicola, additional, Quagliariello, Vincenzo, additional, Ricciardi, Giuseppina Rosaria, additional, Lestuzzi, Chiara, additional, Fiscella, Damiana, additional, Parrini, Iris, additional, Racanelli, Vito, additional, Russo, Antonio, additional, Incorvaia, Lorena, additional, Calabrò, Fabio, additional, Curigliano, Giuseppe, additional, Cinieri, Saverio, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

31. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Abrignani, Maurizio Giuseppe, additional, Di Fusco, Stefania Angela, additional, Parrini, Iris, additional, Canale, Maria Laura, additional, Giubilato, Simona, additional, Cornara, Stefano, additional, Nesti, Martina, additional, Rao, Carmelo Massimiliano, additional, Pozzi, Andrea, additional, Binaghi, Giulio, additional, Maloberti, Alessandro, additional, Ceravolo, Roberto, additional, Bisceglia, Irma, additional, Rossini, Roberta, additional, Temporelli, Pier Luigi, additional, Amico, Antonio Francesco, additional, Calvanese, Raimondo, additional, Gelsomino, Sandro, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

33. Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update

Author

Lucà, Fabiana, primary, Oliva, Fabrizio, additional, Rao, Carmelo Massimiliano, additional, Abrignani, Maurizio Giuseppe, additional, Amico, Antonio Francesco, additional, Di Fusco, Stefania Angela, additional, Caretta, Giorgio, additional, Di Matteo, Irene, additional, Di Nora, Concetta, additional, Pilleri, Anna, additional, Ceravolo, Roberto, additional, Rossini, Roberta, additional, Riccio, Carmine, additional, Grimaldi, Massimo, additional, Colivicchi, Furio, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

35. Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention

Author

De Luca, Leonardo, Di Fusco, Stefania Angela, Iannopollo, Gianmarco, Mistrulli, Raffaella, Rizzello, Vittoria, Aimo, Alberto, Navazio, Alessandro, Bilato, Claudio, Corda, Marco, Di Marco, Massimo, Geraci, Giovanna, Iacovoni, Attilio, Milli, Massimo, Pascale, Vittorio, Riccio, Carmine, Scicchitano, Pietro, Tizzani, Emanuele, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention presents a significant barrier to improving patient outcomes. To address this, the utilization of drug combinations, specifically single pill combinations (SPCs) and polypills, was proposed as a strategy to simplify treatment regimens. This approach aims to enhance treatment accessibility, affordability, and adherence, thereby reducing healthcare costs and improving patient health. The document is an Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on simplifying drug regimens for secondary cardiovascular prevention. It discusses the underuse of treatments despite available, effective, and accessible options, highlighting a significant gap in secondary prevention across different socio-economic statuses and countries. The statement explores barriers to implementing evidence-based treatments, including patient, healthcare provider, and system-related challenges. The paper also reviews international guidelines, the role of SPCs and polypills in clinical practice, and their economic impact, advocating for their use in secondary prevention to improve patient outcomes and adherence.

Published
2024
Full Text
View/download PDF

36. Cardio-oncology rehabilitation: are we ready?

Author

Bisceglia, Irma, Venturini, Elio, Canale, Maria Laura, Ambrosetti, Marco, Riccio, Carmine, Giallauria, Francesco, Gallucci, Giuseppina, Abrignani, Maurizio G, Russo, Giulia, Lestuzzi, Chiara, Mistrulli, Raffaella, De Luca, Giovanni, Maria Turazza, Fabio, Mureddu, Gianfrancesco, Di Fusco, Stefania Angela, Lucà, Fabiana, De Luca, Leonardo, Camerini, Andrea, Halasz, Geza, Camilli, Massimiliano, Quagliariello, Vincenzo, Maurea, Nicola, Fattirolli, Francesco, Gulizia, Michele Massimo, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar of preventive cardio-oncology. Cardio-oncology rehabilitation is a comprehensive model based on a multitargeted approach and its efficacy has been widely documented; when compared with an ‘exercise only’ programme, comprehensive CORE demonstrates a better outcome. It involves nutritional counselling, psychological support, and cardiovascular (CV) risk assessment, and it is directed to a very demanding population with a heavy burden of CV diseases driven by physical inactivity, cancer therapy-induced metabolic derangements, and cancer therapy-related CV toxicities. Despite its usefulness, CORE is still underused in cancer patients and we are still at the dawning of remote models of rehabilitation (tele-rehabilitation). Not all CORE is created equally: a careful screening procedure to identify patients who will benefit the most from CORE and a multidisciplinary customized approach are mandatory to achieve a better outcome for cancer survivors throughout their cancer journey. The aim of this paper is to provide an updated review of CORE not only for cardiologists dealing with this peculiar population of patients but also for oncologists, primary care providers, patients, and caregivers. This multidisciplinary team should help cancer patients to maintain a healthy and active life before, during, and after cancer treatment, in order to improve quality of life and to fight health inequities.

Published
2024
Full Text
View/download PDF

37. Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’

Author

Lucà, Fabiana, Pavan, Daniela, Gulizia, Michele Massimo, Manes, Maria Teresa, Abrignani, Maurizio Giuseppe, Benedetto, Francesco Antonio, Bisceglia, Irma, Brigido, Silvana, Caldarola, Pasquale, Calvanese, Raimondo, Canale, Maria Laura, Caretta, Giorgio, Ceravolo, Roberto, Chieffo, Alaide, Chimenti, Cristina, Cornara, Stefano, Cutolo, Ada, Di Fusco, Stefania Angela, Di Matteo, Irene, Di Nora, Concetta, Fattirolli, Francesco, Favilli, Silvia, Francese, Giuseppina Maura, Gelsomino, Sandro, Geraci, Giovanna, Giubilato, Simona, Ingianni, Nadia, Iorio, Annamaria, Lanni, Francesca, Montalto, Andrea, Nardi, Federico, Navazio, Alessandro, Nesti, Martina, Parrini, Iris, Pilleri, Annarita, Pozzi, Andrea, Rao, Carmelo Massimiliano, Riccio, Carmine, Rossini, Roberta, Scicchitano, Pietro, Valente, Serafina, Zuccalà, Giuseppe, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

It has been well assessed that women have been widely under-represented in cardiovascular clinical trials. Moreover, a significant discrepancy in pharmacological and interventional strategies has been reported. Therefore, poor outcomes and more significant mortality have been shown in many diseases. Pharmacokinetic and pharmacodynamic differences in drug metabolism have also been described so that effectiveness could be different according to sex. However, awareness about the gender gap remains too scarce. Consequently, gender-specific guidelines are lacking, and the need for a sex-specific approach has become more evident in the last few years. This paper aims to evaluate different therapeutic approaches to managing the most common women’s diseases.

Published
2024
Full Text
View/download PDF

38. Italian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer

Author

Di Fusco, Stefania Angela, Mocini, Edoardo, Gori, Mauro, Iacoviello, Massimo, Bilato, Claudio, Corda, Marco, De Luca, Leonardo, Di Marco, Massimo, Geraci, Giovanna, Iacovoni, Attilio, Milli, Massimo, Navazio, Alessandro, Pascale, Vittorio, Riccio, Carmine, Scicchitano, Pietro, Tizzani, Emanuele, Gabrielli, Domenico, Grimaldi, Massimo, Colivicchi, Furio, and Oliva, Fabrizio

Abstract

Obesity is a chronic and relapsing disease characterized by the interaction between individual predispositions and an obesogenic environment. Recent advances in understanding the mechanisms of energetic homoeostasis paved the way to more effective therapeutic approaches compared with traditional treatments. Since obesity is a complex disease, it necessitates a multi-disciplinary approach whose implementation remains challenging. Nonetheless, emerging pharmacological interventions appear promising. Currently, therapeutic success is discreet in the short term but often fails to maintain long-term weight loss due to a high likelihood of weight regain. Cardiologists play a key role in managing patients with obesity, yet often lack familiarity with its comprehensive management. The aim of this document is to summarize knowledge to consolidate essential knowledge for clinicians to effectively treat patients living with obesity. The paper emphasizes the pivotal role of a strong patient–clinician relationship in navigating successful treatment. We analyse the criteria commonly used to diagnose obesity and point out the strengths and limitations of different criteria. Furthermore, we discuss the role of obesiologists and the contributions of cardiologists. In addition, we detail key components of effective therapeutic strategies, including educational aspects and pharmacological options.

Published
2024
Full Text
View/download PDF

39. [Cardiology as seen through social media]

Author

Castelletti, Silvia, Di Fusco, Stefania Angela, Borrelli, Nunzia, Gragnano, Felice, Perone, Francesco, Colivicchi, Furio, Castelletti, Silvia, Di Fusco, Stefania Angela, Borrelli, Nunzia, Gragnano, Felice, Perone, Francesco, and Colivicchi, Furio

Subjects
Cardiology, Humans, COVID-19, Social Media, Pandemics, Cardiovascular System
Abstract

The use of social media (SoMe) has spread worldwide among doctors, scientific societies, and researchers. SoMe offer a powerful platform to accelerate or create new contacts, spread scientific news, and increase visibility. A social media promotion strategy for cardiovascular medicine papers seems to be associated with increased online visibility and a higher number of citations. This effect is independent of the type of article and the total number of followers of the authors. Indeed, SoMe are democratic and even non-senior researchers may be popular on Twitter: your title is not as important as what you do on Twitter. Nevertheless, some physicians may be over-celebrated due to their presence on SoMe. This is why a new author index, the K-index, has been proposed. The K-index correlates the citations of a scientist with the number of Twitter followers. Even scientific journals and societies have recognized the importance of SoMe and in the last years they have appeared on SoMe with official accounts. Therefore, besides the classic impact factor, publishers now pay more and more attention to other parameters, such as the Altmetric score, which takes into account the number of citations, but also the number of downloads, mentions on SoMe, newspapers and tv news, web sites, and blogs. The COVID-19 pandemic has boosted the importance of SoMe for scientific content distribution, particularly for congresses. For all these reasons, it is important to understand the pros and cons of SoMe. It is also possible that SoMe will become a new education medium for continuing medical education.

Published
2022

40. Anderson–Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement.

Author

Iorio, Annamaria, Lucà, Fabiana, Pozzi, Andrea, Rao, Carmelo Massimiliano, Chimenti, Cristina, Di Fusco, Stefania Angela, Rossini, Roberta, Caretta, Giorgio, Cornara, Stefano, Giubilato, Simona, Di Matteo, Irene, Di Nora, Concetta, Pilleri, Anna, Gelsomino, Sandro, Ceravolo, Roberto, Riccio, Carmine, Grimaldi, Massimo, Colivicchi, Furio, Oliva, Fabrizio, and Gulizia, Michele Massimo

Subjects
ANGIOKERATOMA corporis diffusum, ARRHYTHMIA, LEFT ventricular hypertrophy, EARLY diagnosis, SUDDEN death, GENETIC testing
Abstract

Anderson–Fabry disease (AFD) is a lysosome storage disorder resulting from an X-linked inheritance of a mutation in the galactosidase A (GLA) gene encoding for the enzyme alpha-galactosidase A (α-GAL A). This mutation results in a deficiency or absence of α-GAL A activity, with a progressive intracellular deposition of glycosphingolipids leading to organ dysfunction and failure. Cardiac damage starts early in life, often occurring sub-clinically before overt cardiac symptoms. Left ventricular hypertrophy represents a common cardiac manifestation, albeit conduction system impairment, arrhythmias, and valvular abnormalities may also characterize AFD. Even in consideration of pleiotropic manifestation, diagnosis is often challenging. Thus, knowledge of cardiac and extracardiac diagnostic "red flags" is needed to guide a timely diagnosis. Indeed, considering its systemic involvement, a multidisciplinary approach may be helpful in discerning AFD-related cardiac disease. Beyond clinical pearls, a practical approach to assist clinicians in diagnosing AFD includes optimal management of biochemical tests, genetic tests, and cardiac biopsy. We extensively reviewed the current literature on AFD cardiomyopathy, focusing on cardiac "red flags" that may represent key diagnostic tools to establish a timely diagnosis. Furthermore, clinical findings to identify patients at higher risk of sudden death are also highlighted. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

Author

Lucà, Fabiana, primary, Colivicchi, Furio, additional, Oliva, Fabrizio, additional, Abrignani, Maurizio, additional, Caretta, Giorgio, additional, Di Fusco, Stefania Angela, additional, Giubilato, Simona, additional, Cornara, Stefano, additional, Di Nora, Concetta, additional, Pozzi, Andrea, additional, Di Matteo, Irene, additional, Pilleri, Anna, additional, Rao, Carmelo Massimiliano, additional, Parlavecchio, Antonio, additional, Ceravolo, Roberto, additional, Benedetto, Francesco Antonio, additional, Rossini, Roberta, additional, Calvanese, Raimondo, additional, Gelsomino, Sandro, additional, Riccio, Carmine, additional, and Gulizia, Michele Massimo, additional

Published
2023
Full Text
View/download PDF

42. Management of temporary mechanical circulatory support devices in cath-lab and cardiac intensive care unit

Author

Fortuni, Federico, primary, Zilio, Filippo, additional, Iannopollo, Gianmarco, additional, Ciliberti, Giuseppe, additional, Trambaiolo, Paolo, additional, Ceriello, Laura, additional, Musella, Francesca, additional, Scicchitano, Pietro, additional, Albani, Stefano, additional, Di Fusco, Stefania Angela, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

43. ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy

Author

Di Fusco, Stefania Angela, primary, Alonzo, Alessandro, additional, Aimo, Alberto, additional, Matteucci, Andrea, additional, Intravaia, Rita Cristina Myriam, additional, Aquilani, Stefano, additional, Cipriani, Manlio, additional, De Luca, Leonardo, additional, Navazio, Alessandro, additional, Valente, Serafina, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

44. Italian Association of Hospital Cardiologists practical guidance for sodium–glucose cotransporter 2 inhibitors use in patients with heart failure

Author

Di Fusco, Stefania Angela, primary, Spinelli, Antonella, additional, Aquilani, Stefano, additional, Borrelli, Nunzia, additional, Iannopollo, Gianmarco, additional, Gulizia, Michele Massimo, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2023
Full Text
View/download PDF

47. Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks

Author

Pino, Paolo G., primary, Madeo, Andrea, additional, Lucà, Fabiana, additional, Ceravolo, Roberto, additional, di Fusco, Stefania Angela, additional, Benedetto, Francesco Antonio, additional, Bisignani, Giovanni, additional, Oliva, Fabrizio, additional, Colivicchi, Furio, additional, Gulizia, Michele Massimo, additional, and Gelsomino, Sandro, additional

Published
2023
Full Text
View/download PDF

48. Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management

Author

Lucà, Fabiana, primary, Pino, Paolo G., additional, Parrini, Iris, additional, Di Fusco, Stefania Angela, additional, Ceravolo, Roberto, additional, Madeo, Andrea, additional, Leone, Angelo, additional, La Mair, Mark, additional, Benedetto, Francesco Antonio, additional, Riccio, Carmine, additional, Oliva, Fabrizio, additional, Colivicchi, Furio, additional, Gulizia, Michele Massimo, additional, and Gelsomino, Sandro, additional

Published
2023
Full Text
View/download PDF

50. Women at heart: Introducing gender cardio-oncology

Author

Canale, Maria Laura, primary, Bisceglia, Irma, additional, Gallucci, Giuseppina, additional, Russo, Giulia, additional, Camerini, Andrea, additional, Di Fusco, Stefania Angela, additional, Paccone, Andrea, additional, Camilli, Massimiliano, additional, Fiscella, Damiana, additional, Lestuzzi, Chiara, additional, Turazza, Fabio Maria, additional, Gulizia, Michele Massimo, additional, Pavan, Daniela, additional, Maurea, Nicola, additional, Gabrielli, Domenico, additional, Oliva, Fabrizio, additional, and Colivicchi, Furio, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results